![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-desktop-header-01gif-33629.gif)
![Renejix CDMO Partner for Small Molecule Oral Dosage Forms](https://www.pharmacompass.com/image/flap/renejix-w35-mob-header-01gif-17728.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/08/27/2936158/0/en/Centessa-Pharmaceuticals-Announces-Late-Breaking-Poster-Presentation-of-Non-Human-Primate-Data-for-ORX142-a-Novel-Orexin-Receptor-2-OX2R-Agonist-at-the-27th-Congress-of-the-Europea.html
https://www.globenewswire.com/news-release/2024/08/21/2933468/0/en/Centessa-Pharmaceuticals-to-Participate-in-the-Morgan-Stanley-22nd-Annual-Global-Healthcare-Conference.html
https://www.globenewswire.com/news-release/2024/08/13/2929060/0/en/Centessa-Pharmaceuticals-Reports-Financial-Results-and-Business-Highlights-for-the-Second-Quarter-of-2024.html
https://www.globenewswire.com/news-release/2024/06/10/2895873/0/en/Centessa-Pharmaceuticals-Strengthens-Executive-Leadership-with-Appointment-of-John-Crowley-CPA-as-Chief-Financial-Officer-and-Gregory-Weinhoff-MD-MBA-as-Chief-Business-Officer.html
https://www.globenewswire.com/news-release/2024/05/30/2890436/0/en/Nxera-Pharma-to-Receive-4-6-Million-in-Milestone-Payments-from-Centessa-Pharmaceuticals.html
https://www.globenewswire.com/news-release/2024/05/21/2885606/0/en/Centessa-Pharmaceuticals-to-Participate-in-Upcoming-Investor-Conferences.html
https://www.globenewswire.com/news-release/2024/05/13/2880886/0/en/Centessa-Pharmaceuticals-Reports-Financial-Results-and-Business-Highlights-for-the-First-Quarter-of-2024.html
https://www.globenewswire.com/news-release/2024/04/24/2868241/0/en/Centessa-Pharmaceuticals-Announces-Pricing-of-100-Million-Public-Offering-of-American-Depositary-Shares.html
https://www.globenewswire.com/news-release/2024/04/23/2868154/0/en/Centessa-Pharmaceuticals-Announces-100-Million-Proposed-Public-Offering-of-American-Depositary-Shares.html
https://www.globenewswire.com/news-release/2024/04/22/2866726/0/en/Centessa-Pharmaceuticals-Announces-Open-IND-for-ORX750-Proof-of-Concept-Data-in-Sleep-Deprived-Healthy-Volunteers-Planned-for-2H-2024.html